NCT05739942
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05739942
Title Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
University of California LA Los Angeles California 90095 United States Details
University of Colorado Denver Aurora Colorado 80045 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Ctr New York New York 10065 United States Details
Univ Hosp Cleveland Medical Center Cleveland Ohio 44106-5028 United States Details
Uni of Utah Huntsman Cancer Inst Salt Lake City Utah 84103 United States Details
Novartis Investigative Site Dijon Cote D Or 21034 France Details
Novartis Investigative Site Marseille 13885 France Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site München 80377 Germany Details
Novartis Investigative Site Rostock 18057 Germany Details
Novartis Investigative Site Jerusalem 9112001 Israel Details
Novartis Investigative Site Reggio Emilia RE 42123 Italy Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Granada Andalusia 18014 Spain Details
Novartis Investigative Site Badalona Catalonia 08916 Spain Details
Novartis Investigative Site Barcelona Catalonia 08003 Spain Details
Novartis Investigative Site Barcelona 08907 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Liverpool CH63 4JY United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field